Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dilutive or Non-Dilutive Funding …
Welcome back, Mark, after all that time! Can you show us or give us a link where it is stated that The Phoenix Group/Phoenix Technology is the majority shareholder of the TCRI shell? Thanks!
May we know where you find this “Curallo” information. Link? Thanks.
GEMZ Corporation (OTC: GMZP) is announcing that the Company recently had a change in management. Stephen Carnes was recently appointed and accepted the positions of CEO, President, and sole Director of GEMZ Corporation. The Company has relocated its corporate address to Winter Park, FL where Mr. Carnes maintains corporate offices for his growing portfolio of companies.
Stephen Carnes, CEO of GMZP stated, "I have a clear vision for what I want to accomplish for both the short term and long term future of the company. I believe that the right strategy is quickly being put in place to achieve success for both the company and shareholders. I am fast tracking an acquisition for the company, and I look forward to sharing details with shareholders as quickly as I can get everything processed.”
Carnes further stated, “I have submitted the necessary paperwork and application to OTC Markets to request access to OTCIQ in order to upload filings for the company as well as update and make additional changes to the company’s profile. The company now has an official Twitter account, which you can find listed below in today’s press release. Additionally, the company’s profile on OTC Markets will be updated with the Twitter account once access is granted to make such updates.”
The Company will share additional news via Twitter, press releases and OTC Markets once account access has been approved.
Follow us on Twitter at: @GEMZCorporation
https://newsdirect.com/news/gemz-corporation-announces-change-in-management-official-twitter-account-established-846433738
Indeed, or one reverse split after another as Rennova is doing. They know how it works….
The short sale volume percent (not short interest) for stock ticker RNVA is 71.82% on Oct 07, 2022. The short sale volume is 2,868,144,049. The total volume is 3,993,441,320. The short sale volume percent is down -22.66% compare to Oct 06, 2022
And even short…
The short sale volume percent (not short interest) for stock ticker RNVA is 100% on Sep 30, 2022. The short sale volume is 7,822,500. The total volume is 7,822,500. The short sale volume percent is up 7.34% compare to Sep 29, 2022.
I don’t think so:
The short sale volume percent (not short interest) for stock ticker VMCS is 40.17% on Sep 23, 2022. The short sale volume is 201,613. The total volume is 501,857. The short sale volume percent is up 35.59% compare to Sep 22, 2022.
Almost 60% short volume after good news, not so bad …
The short sale volume percent (not short interest) for stock ticker KRTL is 59.44% on Sep 20, 2022. The short sale volume is 205,105. The total volume is 345,046. The short sale volume percent is up 24.93% compare to Sep 19, 2022.
InnovaQor Announces That Its Form 10-12G Registration Statement will become effective on September 27, 2022.
September 14, 2022 9:00am EDT
WEST PALM BEACH, Fla., Sept. 14, 2022 (GLOBE NEWSWIRE) -- InnovaQor, Inc. (A Nevada corporation) (OTC: VMCS), today announced that it will become a fully SEC reporting company when its Form 10-12G becomes automatically effective on September 27, 2022.
The company will begin filing annual reports with the SEC on Form 10-K, quarterly reports on Form 10-Q, and periodic reports on Form 8-K, and subject itself to additional reporting obligations related to proxies, shareholder actions and stock ownership rules.
“Our transition to a fully reporting company will create increased transparency and accountability to current shareholders and should enable us to attract new and more sophisticated investors as we endeavor to build a successful business” said Sharon Hollis, CEO of InnovaQor, Inc. “We look forward to changing our stock trading symbol and completing any remaining items required to finalize the change of our name to InnovaQor, Inc., on all platforms”.
Yes indeed and only 69% was short, not so bad, great day…!
The short sale volume percent (not short interest) for stock ticker KRTL is 69.41% on Sep 13, 2022. The short sale volume is 553,886. The total volume is 798,021. The short sale volume percent is up 18.94% compare to Sep 12, 2022.
Oh no, I meant he is also responsible for all of what is going on and wrong but till now he is living very well with it and in most of the cases that’s most important for them.
You can vote: Better - Worse - The beginning of the End
The only hope or is it just the opposite: halve of Dabs family is in ?
Net Revenues
Net revenues were $468,883 and $528,624 for the years ended December 31, 2021 and 2020, respectively. Revenues went down as a result of customers leaving due to various reasons such as being acquired or going out of business.
Net Loss
Our net loss was $845,843 for the year ended December 31, 2021, as compared to a net loss of $606,451 for the year ended December 31, 2020. The $239,392 increase in net loss was principally due to the increases in our general and administrative expenses and direct costs of revenue.
Becoming better or worse?
Net Revenues
Net revenues were $95,893 and $118,217 for the three months ended March 31, 2022 and 2021, respectively. Net revenues went down as a result of customers leaving due to various reasons such as being acquired and going out of business and we are not marketing as a result of lack of funds. This period does not include annual renewals that would increase the revenues for the period.
Net Loss
Our net loss was $264,723 for the three months ended March 31, 2022, as compared to a net loss of $175,963 for the three months ended March 31, 2021. The $88,760 increase in net loss was principally due to the increases in our direct cost of revenue expenses.
To make it complex and deeper and deeper?
During the three months ended March 31, 2022, Ms. Hollis, the Chief Executive Officer of the Company, loaned the Company $84,100. The Company entered into a promissory note in the amount of $92,510, representing a 10% original issue discount. The loan is due on September 6, 2022; provided that, 50% is due if the Company receives $500,000 of financing and 100% is due if the Company receives $1,000,000 of financing. In addition, the Company issued Ms. Hollis 25 shares of Series C Preferred Stock on March 31, 2022 in connection with the loan.
… and director (one of the 3) see last Form
Justin Doherty 54 Director, Chairman
Sharon L. Hollis 45 Director, President, CEO
Gerard Dab 74 Director, Secretary
Indeed, thanks. We must wait and see if this is a fact of time or if there is another reason.
According OTC this is still a shell. For that reason many brokers don’t allow a buy order. Anyone any idea why this is still a shell?
Sharon Hollis of Rennova, new CEO of VisualMed???
We are pleased to report progress from our efforts to become more compliant and transparent for investors” said Sharon Hollis, CEO of VisualMed, “and look forward to completing a name change and launching our website to better disclose and advertise what we believe are exciting software solutions for the healthcare sector.”
Confirmation from Rennova:
“ Once the agreement has closed VisualMed intends to complete a name change and file audited financial statements and other filings as required to become fully reporting with the SEC ”
And where is G. Dab? Having a nap in Paris? Maybe he still don’t know it.
This could be important news, for once in the last 15 years.
If you have a look at their “Healthcare Technology Solutions”, there is still hope for VMCS.
https://www.rennovahealth.com/services
www.rennovahealth.com
https://www.rennovahealth.com/services/overview
... we “intend” to resume ... and as usual he has not mentioned the year...
In any case, thank you for sharing this.
The problem with Dab is that you can’t trust a single word of what he’s telling. The only thing he is interested in, is money (for himself). So it’s possible he is building up some resistance to fill more he’s pockets. The same way he was “giving away” VSHC. After years, he was waking up for some reason. Any valuable assets of VMCS can be shifted now to the company of his daughter he created. It also had a reason.... But we will see.
Why are you so frustrated ?
You’re against VMCS, against SSM, against everyone and everything.
So what are you doing here, what is your purpose?
You missed the boat?
This is how SSM Monopoly works.
We're sitting now in the left circle. The next is next month (before granted). The rocket at the right side is after granted. Next step is merger. Will we see the same race? It's possible.
You can now understand why some are very frustrated when sold early.
You want to sell some to them at this price? It's your choice, everybody is free and must decide for himself. It's always a bit gambling.
Could this be the reason?
Michel Dab (son of Gerard, worked years ago for VMCS, is the only person who is still registered together with his father in the "dead" company VMCS).
Is running now, as CEO, the rather new company Cannamerx - Cannabis Mercantile Exchange.
Does he want “to go public” to raise capital?
Cannamerx is the fully automated international auction platform for wholesale cannabis & hemp products, and genetics.
https://www.cannamerx.com
Developed in close collaboration with the legal cannabis industry, Cannamerx is designed to facilitate trade in bulk cannabis, hemp, and cannabis & hemp products between licensed producers worldwide.
We are a proudly Canadian company, launched in November 2017. With more participants joining our growing international community of buyers and sellers every week, Cannamerx is the first international cannabis and hemp exchange platform of its kind – a true mercantile exchange for this emerging industry.
Our international transaction capability launched in October 2018, while trading of hemp and hemp products was made available in March 2019. If you are a legal cannabis or hemp actor in your jurisdiction, Cannamerx is the best place to auction your current and future supply to the world.
“Opal” is the new app of McGill. It’s just the beginning and will be expanded to other centres and doctors. They still hiring people for this project. If VMCS is involved, I don’t know but they were years ago in the McGill Health Centre.
https://www.opalmedapps.com/
https://ici.radio-canada.ca/nouvelle/1454856/cancer-cusm-application-dossier-doigts
https://publications.mcgill.ca/medenews/2019/06/06/patient-empowerment-app-opal-wins-prix-dexcellence-honour/
In any case it seems that Michel Maksud is working there as “a Consultant applications mobiles”.
Michel Maksud (Medicool Health Systems Inc.)
Vice president technology VisualMed Clinical solutions (from 2000 till 2006)
Consultant applications mobiles at Centre universitaire de santé McGill (From 10-2018 till …)
According the Canadian Federal Corporation Information, Medicool is still Active and VisualMed is Dissolved for non-compliance
Medicool
https://www.ic.gc.ca/app/scr/cc/CorporationsCanada/fdrlCrpDtls.html?corpId=3742971
VisualMed
https://www.ic.gc.ca/app/scr/cc/CorporationsCanada/fdrlCrpDtls.html?corpId=3440231
For what it is worth, not so much I think, but maybe better than nothing, even if it won’t please you.
Kind regards
Job Description
RESEARCH INSTITUTE OF THE MUHC
The Research Institute of the McGill University Health Centre (RI-MUHC) is a world-renowned biomedical and hospital research centre. Located in Montreal, Quebec, the Institute is the research arm of the McGill University Health Centre (MUHC) affiliated with the Faculty of Medicine at McGill University. The RI-MUHC is supported in part by the Fonds de recherche du Québec - Santé (FRQS).
Position summary
Interested in coding the healthcare system of the future?
The Opal team is hiring!
Recently named eHealth solution of 2019 by Le Point
Health and Social Services, recipient of the 2019
Minister’s choice–prize of excellence from the Quebec
Ministry of Health and the 2019 Trottier-Webster Award
for Innovation at the RI-MUHC, the Opal patient portal
smartphone app is designed as a one-stop empowerment tool for patients.
Opal provides patients with access to their medical
appointments, appointment check-in, clinical notes, test
results, personalized educational materials, and symptom questionnaires.
This full-time software developer position is for one year with a possibility for long-term employment. Competitive salary commensurate with proven experience and expertise
Tesla had a huge estimated price-earnings ratio of 98 for 2020?
For GM this was 6.
Shares of automakers slided after new-car sales slump.
When can we expect a profit warning from Tesla?
Better they don’t wait too long, with such an extreme ratio.
Two viruses now for Tesla?
GM soon 20 different EV's.
400 mile batteries with -70% Cobalt.
Full power and cheaper.
https://www.theverge.com/2020/3/4/21164513/gm-ev-platform-architecture-battery-ultium-tesla